Patents by Inventor James S. Wright

James S. Wright has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8952073
    Abstract: The presently disclosed and claimed inventive concept(s) provides new estrogenic compounds of the general formula and pharmaceutical compositions containing them. The compounds of the presently disclosed and claimed inventive concept(s) are useful, for example, in hormone replacement therapies (HRT/ERT), and as contraceptives, and estrogenic hormone therapies. Also provided is a process for synthesizing the compounds of the presently disclosed and claimed inventive concept(s).
    Type: Grant
    Filed: June 7, 2013
    Date of Patent: February 10, 2015
    Assignee: University of Ottawa
    Inventors: Hooman Shadnia, James S. Wright, Tony Durst, Muhammad Asim, Christine Pratt
  • Publication number: 20130274344
    Abstract: The presently disclosed and claimed inventive concept(s) provides new estrogenic compounds of the general formula and pharmaceutical compositions containing them. The compounds of the presently disclosed and claimed inventive concept(s) are useful, for example, in hormone replacement therapies (HRT/ERT), and as contraceptives, and estrogenic hormone therapies. Also provided is a process for synthesizing the compounds of the presently disclosed and claimed inventive concept(s).
    Type: Application
    Filed: June 7, 2013
    Publication date: October 17, 2013
    Inventors: Hooman Shadnia, James S. Wright, Tony Durst, Muhammad Asim, Christine Pratt
  • Patent number: 8471073
    Abstract: The present invention provides new estrogenic compounds of the general formula in which the substituents have the meanings that are explained in more detail in the description, and pharmaceutical compositions containing them. The compounds of the invention are useful, for example, in hormone replacement therapies (HRT/ERT) and as contraceptives and estrogenic hormone therapies. Also provided is a process for synthesizing the compounds of the invention.
    Type: Grant
    Filed: March 27, 2012
    Date of Patent: June 25, 2013
    Assignee: University of Ottawa
    Inventors: Hooman Shadnia, James S. Wright, Tony Durst, Muhammad Asim
  • Publication number: 20120190898
    Abstract: The present invention provides new estrogenic compounds of the general formula in which the substituents have the meanings that are explained in more detail in the description, and pharmaceutical compositions containing them. The compounds of the invention are useful, for example, in hormone replacement therapies (HRT/ERT) and as contraceptives and estrogenic hormone therapies. Also provided is a process for synthesizing the compounds of the invention.
    Type: Application
    Filed: March 27, 2012
    Publication date: July 26, 2012
    Inventors: Hooman Shadnia, James S. Wright, Tony Durst, Muhammad Asim
  • Patent number: 8158684
    Abstract: The present invention provides new estrogenic compounds of the general formula in which the substituents have the meanings that are explained in more detail in the description, and pharmaceutical compositions containing them. The compounds of the invention are useful, for example, in hormone replacement therapies (HRT/ERT) and as contraceptives and estrogenic hormone therapies. Also provided is a process for synthesizing the compounds of the invention.
    Type: Grant
    Filed: April 21, 2011
    Date of Patent: April 17, 2012
    Assignee: University of Ottawa
    Inventors: Hooman Shadnia, James S. Wright, Tony Durst, Muhammad Asim
  • Publication number: 20110196045
    Abstract: The present invention provides new estrogenic compounds of the general formula in which the substituents have the meanings that are explained in more detail in the description, and pharmaceutical compositions containing them. The compounds of the invention are useful, for example, in hormone replacement therapies (HRT/ERT) and as contraceptives and estrogenic hormone therapies. Also provided is a process for synthesizing the compounds of the invention.
    Type: Application
    Filed: April 21, 2011
    Publication date: August 11, 2011
    Inventors: Hooman Shadnia, James S. Wright, Tony Durst, Muhammad Asim
  • Publication number: 20090234024
    Abstract: The present invention provides new estrogenic compounds of the general formula in which the substituents have the meanings that are explained in more detail in the description, and pharmaceutical compositions containing them. The compounds of the invention are useful, for example, in hormone replacement therapies (HRT/ERT) and as contraceptives and estrogenic hormone therapies. Also provided is a process for synthesizing the compounds of the invention.
    Type: Application
    Filed: February 4, 2009
    Publication date: September 17, 2009
    Inventors: Hooman Shadnia, James S. Wright, Tony Durst, Muhammad Asim